KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Quest Diagnostics (DGX) Other Non Operating Income (2016 - 2026)

Quest Diagnostics' Other Non Operating Income history spans 18 years, with the latest figure at -$2.0 million for Q1 2026.

  • On a quarterly basis, Other Non Operating Income rose 33.33% to -$2.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $27.0 million, a 50.0% increase, with the full-year FY2025 number at $26.0 million, down 13.33% from a year prior.
  • Other Non Operating Income hit -$2.0 million in Q1 2026 for Quest Diagnostics, down from $8.0 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for DGX hit a ceiling of $15.0 million in Q3 2024 and a floor of -$29.0 million in Q2 2022.
  • Historically, Other Non Operating Income has averaged $1.1 million across 5 years, with a median of $6.0 million in 2022.
  • Biggest five-year swings in Other Non Operating Income: plummeted 700.0% in 2022 and later skyrocketed 600.0% in 2024.
  • Tracing DGX's Other Non Operating Income over 5 years: stood at $6.0 million in 2022, then surged by 66.67% to $10.0 million in 2023, then tumbled by 70.0% to $3.0 million in 2024, then skyrocketed by 166.67% to $8.0 million in 2025, then tumbled by 125.0% to -$2.0 million in 2026.
  • Business Quant data shows Other Non Operating Income for DGX at -$2.0 million in Q1 2026, $8.0 million in Q4 2025, and $8.0 million in Q3 2025.